Viewing Study NCT02254967


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT02254967
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2014-09-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population
Sponsor: Astellas Pharma Europe Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module